Schizophrenia and Psychoses

Latest News

Atypical Antipsychotics May Dysregulate Immune Response, Increase Risk for COVID-19

By

Emily Pond

Publish Date September 18, 2020

Short- to intermediate-term exposure to atypical antipsychotic medications may dysregulate adaptive immune responses, increasing susceptibility to respiratory infections like COVID-19.

Psychosis Relapse Common During Assured Antipsychotic Treatment

By

Rose Reeb

Publish Date September 16, 2020

Researchers conducted a systematic review and meta-analysis to assess the incidence and predictors of psychosis relapse in individuals receiving treatment with antipsychotic agents.

Weight Gain, Treatment Interruptions Reported With Second-Generation Antipsychotics for Schizophrenia, Bipolar 1 Disorder

By

Brandon May

Publish Date September 11, 2020

Research was conducted to assess the impact of initiation of treatment with second-generation antipsychotics and treatment interruptions on weight gain in patients with schizophrenia and bipolar 1 disorder.

Individuals With the Greatest Risk for Schizophrenia Incur Declining Health After Stressful Life Events

By

Jessica Nye, PhD

Publish Date September 10, 2020

Untreated stress amongst healthcare professionals can lead to a multitude of issues while prolonged stress can contribute to burnout. In order to ensure the safety of both clinicians and patients, effective and feasible interventions are needed for individuals and organizations.

Machine Learning May Improve Diagnostic Accuracy in Schizophrenia, Autism Spectrum Disorder

By

Heather R. Johnson

Publish Date September 1, 2020

A recent study aimed to assess the ability of classifiers to identify individuals with schizophrenia, autism spectrum disorder, and typical development based on findings from magnetic resonance imaging.

Olanzapine Plus Samidorphan for Schizophrenia Associated With Less Weight Gain

By

Heather R. Johnson

Publish Date August 31, 2020

In a phase 3, double-blind trial, the effect of combined olanzapine and samidorphan treatment compared with treatment with olanzapine alone on the weight profile of patients with schizophrenia was evaluated.

Clozapine Teatment Associated With Increased Risk of COVID-19 Infection

By

Emily Pond

Publish Date August 28, 2020

Associations found between clozapine treatment and an increased risk of COVID-19 infection in patients with schizophrenia-spectrum disorders

COVID-19: Clozapine Treatment Increases Risk for Infection

By

Jessica Nye, PhD

Publish Date August 18, 2020

The risk for COVID-19 infection among clozapine-treated patients is elevated, according to researchers.

Polygenic Risk Scores Predict Progression to Other Disorders in Unipolar Depression

By

Emily Pond

Publish Date July 28, 2020

Polygenic risk scores predict the progression from unipolar depression to bipolar or psychiatric disorders.

Long-Acting Injectable Antipsychotics May Delay Time to First Hospitalization in Early-Phase Schizophrenia

By

Nicole Bowens, PhD

Publish Date July 27, 2020

Compared with usual treatment, the use of long-acting injectable antipsychotics significantly increased the time to first hospitalization in patients with early-phase schizophrenia.